Market Overview
Global Diabetes Care Devices Market size was valued at around 32.56 billion in 2024 and is expected to reach a value of USD 62.43 billion by 2033, at a CAGR of 7.5% over the forecast period (2025–2033).
The Forecast Period of Diabetes Care Devices Market
The global market of diabetes care devices has increased within the past couple of years since the rising occurrence of diabetes cases worldwide has prompted more interest in the proper treatment of the said disease. Generally, diabetes refers to a chronic metabolic disorder characterised by having high levels of blood glucose that has emerged into a great concern in public health due to various complications related with it such as cardiovascular disease, kidney failure, neuropathy and retinopathy. Factors such as increased age, an inactive lifestyle, a bad diet, and increasingly high obesity levels have driven increased prevalence of diabetes and, thus, the requirement for advanced solutions in diabetes care.
Diabetes care devices are one of the most important management tools of blood glucose; hence, they promote the outcome of the patient. Systems for monitoring blood glucose levels include continuous glucose monitors, insulin delivery devices, and other ancillary tools. The use of technology has very dramatically transformed the diabetes management process. Current trends offer them with high-accuracy, convenient, and user-friendly devices. With this, the patient would be given more independence, thus being allowed better communication with the healthcare provider.
It is mainly through public health initiatives and educational programs, that the diabetes management and diagnosis market is expanding. Governments as well as other healthcare organizations across different countries put emphasis on prevention and promote diabetes care devices as a means of reducing the burden of diabetes not only economically but also socially. Increasing healthcare expenditures and improved accessibility of medical devices in developing regions are expanding this market.
High demands for homecare are the big trend currently bending the market now. The needs to make monitoring of glucose levels and self-administration of injections of insulin turn portable and friendly to handle them are very strongly felt since those services can easily be managed far from hospitals while having fewer or minimal visits within the institutions whereby one has managed to minimize contact with such centres. Spreading COVID-19 has made these demands increase for the reason of avoiding more exposures to health units.
Although promising, there are some impediments in the market, namely, the quite expensive price for high-tech appliances, restricted health care access in certain areas, and lack of awareness among underprivileged people. Research and development combined with agreements between governments, health care facilities, and device manufacturers should ease these problems and spur further expansion in the market.
Market Drivers
Increasing Prevalence of Diabetes
- The diabetes care devices market is increasingly driven by the rising prevalence of diabetes. Worldwide, diabetes burden is on the rise because of various reasons including age-related issues, sedentary lifestyles, and unhealthy diets. Urbanization coupled with economic development has led to increased consumption of high-calorie foods along with decreased physical activity, leading to a higher prevalence of obesity, which is also a prime risk factor for Type 2 diabetes. The prevalence of Type 1 diabetes is increasing, especially in children and adolescents, due to genetic and environmental factors. According to the International Diabetes Federation, the number of adults with diabetes is expected to increase from 537 million in 2021 to 643 million by 2030, thus emphasizing the importance of proper diabetes management solutions.
Market Challenge
Costs of Diabetic Care
- Probably the biggest hurdle to diabetic care, even to this day, is cost. As governments work in three- to four-year cycles and have very compartmentalized budgets, spending today to prevent problems later still poses a challenge. The increased utilization of technology will eventually necessitate a return on investment and may, therefore, not lead immediately to lower direct healthcare costs for the treatment of diabetes and for digitization. However, if such solutions are easy to use, time-effective, and accessible for the majority of people living with diabetes (as shown by smartphone applications), they can definitely become a key element in controlling the disease and preventing its progression or postponing its aggravation. It will ultimately lead to reducing or preventing long-term costs in healthcare and other social expenditures.
Market Restraining Factors
High Annual Cost of Devices and Consumables
- A major obstacle to access is the high annual cost of devices and consumables, which is driven by the frequency of product updates and the requirement for a steady supply of ancillary product components (such as CGM sensors, SMBG test strips, and lancets), as well as high markups throughout the supply chain. To SMBG systems are prohibitively costly for most and, especially now, the burden of using those devices with the lifelong treatment regimen for diabetes.
Minimal Public Financing
- State funding for product procurement and supply is very minimal; therefore, access to glucose self-monitoring devices occurs only through private pharmacies. As a result, access depends on individuals' ability to pay out-of-pocket (OOP) for the devices, which leads to unequal access and health inequities.
Segmentation Analysis
The market scope is segmented because of by Type, by End-use.
Based on the Type of the market is segmented into BGM Devices, Insulin Delivery Devices.
Among the two main type segments in the Diabetes Care Devices Market-Blood Glucose Monitoring (BGM) Devices and Insulin Delivery Devices- Blood Glucose Monitoring Devices dominated the market to date. Their dominance can be attributed to how critical these devices are in managing diabetes and also their widespread application among Type 1 and Type 2 patients. BGM devices, including self-monitoring blood glucose (SMBG) devices and continuous glucose monitors (CGMs), are essential for regular glucose level tracking, enabling patients to manage their condition effectively and avoid complications.
Further growth is spurred by technological advancements such as adding Bluetooth connectivity to BGM devices to allow compatibility with smartphones, and real-time monitoring of data for patients. They also find more convenience in BGM devices regarding accuracies and personal insights on glucose levels, increasing adoptability. Moreover, BGM devices reach a larger audience that, in addition to insulin-dependent subjects, includes prediabetes, gestational diabetes, and at-risk populations who need monitoring but do not necessarily require insulin therapy.
Although devices delivering insulin, including insulin pens and pumps, are quite important to the management of insulin-dependent diabetes patients, the user population is relatively much smaller. Insulin therapy is generally prescribed for Type 1 diabetes patients and certain advanced Type 2 diabetes cases, thereby restricting the scope of the segment. On the other hand, BGM devices are used by a far larger patient population, such as those with early or less severe diabetes. This wider applicability makes BGM devices the leading segment in the diabetes care devices market.
Based on the End-use of the market is segmented into Hospitals, Diagnostic Centres, Homecare.
All the end-use segments of the Diabetes Care Devices Market include Hospitals, Diagnostic Centres, and Homecare. The lead in the market is the Homecare segment, which dominates the growing preference of patients for self-monitoring and self-management of diabetes, thereby reducing dependence on hospitals and healthcare facilities for better convenience. Homecare solutions like blood glucose monitors BGMs, continuous glucose monitors CGMs, and insulin delivery devices enable a patient to monitor, manage, and attain the need to control blood glucose levels in real-time at their homes.
Homecare is supported with the rising adoption of user-friendly and portable diabetes care devices. Diabetes is rising globally, and these portable diabetes care devices are going to support this growing global trend. Homecare solutions have been preferred more by patients, as it cuts down the frequency of hospital visits, and patients can monitor themselves regularly without the help of professional people. In addition, advances in digital health and connectivity, with the use of smartphone apps and cloud-based platforms, allow for the sharing of data with healthcare providers, making homecare devices more desirable.
The trend, therefore, has accelerated due to the COVID-19 pandemic. Patients preferred avoiding health-care settings for diminished exposure. The geriatric population, which prefers many chronic conditions to be managed at home, is one of the primary drivers here. Hospitals and diagnostic centres are operated primarily for acute needs and diagnostics, thereby not a significant portion of the diabetes care devices market. Hence, the Homecare segment is leading in adoption and revenue generation due to its convenience, cost-effectiveness, and alignment with patient preferences.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. The market for diabetes care devices is dominated by North America. Among the several reasons that make it so, one major reason behind this dominance is diabetes prevalence in the region, mainly in the United States. Of millions of Americans diagnosed with diabetes each year, millions more are at risk for prediabetes, says the CDC. North America also has good health care infrastructure built in it, with the widespread distribution of advanced medical technology and high diabetes care-related awareness. Strong presence of main market players in this region along with reimbursement policies for diabetes care devices will also drive the leading position.
Asia-Pacific is expected to emerge as the second-fastest-growing region in the global market for diabetes care devices. The prevalence of diabetes has been rising very rapidly in such countries as China, India, and Japan due to rapid urbanization, changes in lifestyle, and increasing obesity rates. The improvement of healthcare infrastructure, increase of healthcare expenditure, and awareness building through government initiatives are also accelerating the growth of this market. The region also offers a large, underserved population base and growing demand for affordable and innovative diabetes care solutions.
Although North America continues to dominate because of its advanced healthcare system and high adoption of innovative devices, the growth potential for Asia-Pacific is fuelled by a large population, increasing investments in healthcare, and rising preventive healthcare measures.
List of Companies Profiled
- Medtronic plc
- Abbott Laboratories
- Hoffmann-La-Ltd.
- Bayer AG
- Lifescan, Inc.
- B Braun Melsungen AG
- Lifescan, Inc.
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc.
- Novo Nordisk
- Arkray, Inc.
Key Industry Developments
In May 2023, an agreement has been reached for Medtronic to acquire the insulin device maker EOFlow. It is expected that Medtronic's ability to service a wider spectrum of diabetics would be improved by integrating EOFlow with their sophisticated continuous glucose monitor (CGM) and Meal Detection Technology algorithm.
In April 2023, Undbio said it will invest USD 100 million in constructing an insulin production manufacturing facility in the United States. The South Korean-based company will establish a new plant in West Virginia to manufacture the necessary insulin and sell its products in the country.
In July 2023, My Diabetes Tutor is a firm that works to raise the standards of living for people with diabetes, and CharmHealth and Bioverge together invested in the firm.
Report Coverage
The report will cover the qualitative and quantitative data on the Global Diabetes Care Devices Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations
Study Period | 2025-33 |
Base Year | 2024 |
Estimated Forecast Year | 2025-33 |
Growth Rate | CAGR of 7.5% from 2025 to 2033 |
Segmentation | By Type, By End-use, By Region |
Unit | USD Billion |
By Type | - BGM Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Sensors
- Transmitters
- Receiver
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
|
By End-use | - Hospitals
- Diagnostic Centers
- Homecare
|
By Application | - Residential
- Commercial
- Industrial
|
By Region | - North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)
|
Global Diabetes Care Devices Market Regional Analysis
North America accounted for the highest xx% market share in terms of revenue in the Diabetes Care Devices market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Diabetes Care Devices. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Diabetes Care Devices companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Diabetes Care Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Diabetes Care Devices Market Report is also available for below Regions and Country Please Ask for that
North America
Europe
- Switzerland
- Belgium
- Germany
- France
- U.K
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Rest of Europe
Asia-Pacific
- India
- Australia
- Philippines
- Singapore
- South Korea
- Japan
- China
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Argentina
- Peru
- Colombia
- Brazil
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Points Covered in the Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
- The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Questions
- How much the global Diabetes Care Devices Market valued?
- Which region has the largest share in 2025 for the global Diabetes Care Devices Market?
- What are the driving factors for the market?
- Which is the leading segment in the global market?
- What are the major players in the market?
Research Scope of Diabetes Care Devices Market
- Historic year: 2020-2023
- Base year: 2024
- Forecast: 2025 to 2033
- Representation of Market revenue in USD Million
Diabetes Care Devices Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: